TP53 and glioblastoma: Molecular studies conducted on glioblastoma xenografts have revealed that the overexpression of miR-7-1-3p enhances the effectiveness of the combination of luteolin and silibinin in monitoring the in vivo growth of human glioblastoma harboring wild-type p53 or mutant p53 [138].